Updated proxy to detail recent engagement
with Dazheng
BEIJING, Jan. 31,
2024 /PRNewswire/ -- The Board of Directors
of Hollysys Automation Technologies Ltd. ("Hollysys" or the
"Company") today issued a letter to shareholders reiterating its
support for the proposed acquisition of the Company by a buyer
controlled by Ascendent Capital Partners ("Ascendent") at the
upcoming extraordinary general meeting to be held on February 8, 2024. In the letter, the Company also
addressed statements published
by Dazheng Group Acquisition Limited ("Dazheng").
Also, in a proxy supplement to be filed today, the Company sets
out in detail its engagement with Dazheng as part of its rigorous
process to maximize value for Hollysys shareholders.
Below is the full text of the Board's letter to
shareholders:
Dear Fellow Shareholders:
We write today to reiterate our strong recommendation to vote
FOR the proposed acquisition of Hollysys Automation Technologies
Ltd. ("Hollysys" or the "Company") by a buyer controlled by
Ascendent Capital Partners ("Ascendent").
Compelling Value in an Uncertain Market
The Special Committee of independent directors (the "Special
Committee") makes this recommendation after careful consideration
and deliberation on delivering the compelling transaction for
shareholders. Ascendent remains the only bidder that has
demonstrated the ability to deliver compelling value that is fully
financed and with a viable pathway to closing.
An offer at a higher price that is not accompanied by
credible financing is not a superior offer.
To the point above, we will file today a proxy supplement which
details the Special Committee's engagement with Dazheng Group
Acquisition Limited ("Dazheng"). We outline why we believe
Dazheng's failure to demonstrate
financing certainty presents
material risks that outweigh the potentially higher price it has
offered.
Ascendent was chosen after a transparent, competitive and
rigorous process
The Special Committee formed on September
29, 2023 comprised highly experienced and reputable
directors acting in the best interests of Hollysys shareholders.
The collective experience of the Special Committee offers a
valuable investor perspective when evaluating strategic options to
maximize shareholders' interests and enhance value.
The Special Committee approached or engaged with ten potential
buyers, including the management consortium and the Recco
consortium (which became Dazheng), received three unsolicited
inbound inquiries and shortlisted two bidders. Following execution
of the merger agreement with Ascendent, the Special Committee
solicited interest of seven potential buyers during the go-shop
period and received two proposals (including the Dazheng proposal),
none of which provided the certainty of the Ascendent
transaction.
Failing to vote FOR the Ascendent transaction on February 8, 2024 could result in a dramatic
decline in share price given the current market conditions – as of
January 29, 2024, the S&P China
Select ADR Index is down 24.77% over a 12-month period.
ISS and Glass Lewis focused on the past, and did not give
due credit to the rigorous sale process run by the Special
Committee
The Board strongly disagrees with the recommendations of ISS and
Glass Lewis. Neither ISS nor Glass Lewis provided a judgement on
the value of the Ascendent offer and their recommendations
do not take into account the merits
of the Ascendent transaction, and instead focused on corporate
governance matters extending back many years. The Special Committee
ran a transparent, competitive and rigorous sale process. After a
thorough sale process, there can be no assurance that any other
credible, well-financed buyers would emerge should the Ascendent
transaction be voted down. In its report, ISS itself acknowledges
that if there is no transaction the Company's share price is likely
to fall significantly, underscoring the risk of a vote against the
transaction.
The ISS report does not
recognize that the US$26.50 per share
all-cash consideration offered by Ascendent is the only proposal
that offers compelling valuation and is both fully financed and
with a viable pathway to closing. The price represents a 42%
premium to the unaffected price as of August
23, 2023, and a 52% premium over the 30-day VWAP through the
same date. ISS itself reports that the shares "have appreciated by
102.2%" from December 7, 2020 (when
the Company received the first unsolicited proposal) to
January 23, 2024, "an impressive
triple-digit percent point gain", and "the merger consideration
represents a 111.8% premium to the unaffected price on the day
prior to the announcement." These premiums are substantial compared
to similar transactions.
Dazheng has not delivered a superior proposal
The shifting nature of the
equity members of Dazheng is not consistent with a buyer that has
fully committed and available capital to consummate a transaction.
Since it became the "Dazheng" consortium, when its revised proposal
dropped the names of Recco Control Technology Pte. Ltd and Great
Wall Capital Co., Ltd., its consortium members have changed four
times, as illustrated in the chart.
Contrary to its assertion, no credible equity financing has been
presented to the Special Committee. In its latest proposal,
Dazheng's most significant equity provider is not a well-known
institutional investor but an "affiliate" that does not have the
financial wherewithal to back up its contractual commitment.
Dazheng has repeatedly rejected reasonable requests from the
Special Committee for proper financial arrangement to provide
certainty of funds. Multiple requests made by the Special Committee
over the past weeks to speak with the ultimate equity funders were
turned down. To this day, uncertainties related to Dazheng's
funding remain.
To understand the situation requires a full understanding of who
Dazheng is and how they have acted. Full details are provided in
the Company's proxy statement and its supplement. The table below
illustrates the facts of Dazheng's engagement with the Special
Committee.
Dazheng
Claim
|
Reality
|
"The Consortium's
proposal is
backed by secured and
credible financing…The latest
structure of source of funding
include an entity associated
with a well-known
institutional investor"
|
•
The Consortium's composition has changed
four times
since the submission of the revised
proposal.
•
The latest "investor" providing more than
a majority of
the Consortium's equity funding is a special
purpose
vehicle with no track record of any major
acquisitions.
•
Reasonable requests from the Special
Committee for the
Dazheng Consortium to put in place appropriate
arrangements for certainty of funds have been
repeatedly rejected by the Dazheng
Consortium.
•
Dazheng consistently failed to show
ability to transact
with offshore USD funding and was only willing to
put
"money on the line" in RMB.
|
"Engaging in good
faith, the
Consortium aimed to present
a Superior Proposal"
|
•
Dazheng took two months to resolve NDA
comments
with limited attempts to compromise, which was
atypical
compared to multiple other parties who quickly
signed
similar agreements to participate in the bidding
process.
•
Dazheng disregarded reasonable requests
from the
Special Committee to demonstrate financing
certainty.
•
Dazheng did not accommodate a meeting
with its
primary
equity providers until this past weekend, despite
multiple requests from the Special Committee over the
past weeks.
•
Dazheng ignored the go-shop outreach
until close to the
expiry of the go-shop period.
•
Dazheng's public announcements have been
inconsistent
with their private engagement with the Special
Committee and its advisors.
|
"Buyer Consortium
is
astonished by the
discrimination, ignorance of
shareholder rights and
malfunctioning of the sale
process to date"
|
•
The Special Committee has conducted a
transparent,
competitive and rigorous process throughout the
bidding
process, during the go-shop period up to the present
time.
•
Even after the go-shop period, the
Special Committee
held over ten meetings with its advisors to discuss
next
steps as to engagements with Dazheng.
|
"The hasty execution of
a
merger agreement with
Ascendent"
|
•
Ascendent was the only bidder that has
emerged after
a two-month process with an offer of compelling
value
that is fully financed and with a viable pathway to
closing.
•
While the Company has been rumoured for
sale for more
than two years, private equity firms' interest in
acquiring
ADRs has diminished significantly due to the
macroeconomic and geopolitical environment.
|
Ascendent is a credible independent purchaser offering a
compelling transaction for shareholders
Ascendent is an independent purchaser that is contractually
committed and motivated to complete the acquisition of the Company
in an expedient manner. Contrary to ISS's characterizations,
Ascendent has no affiliation with Dr. Changli Wang, the Company's CEO, and he is not a
part of Ascendent's transaction today. The 2021 bid launched by the
Ascendent-Wang consortium did not proceed because the Board
suspended the sale process after Dr. Wang took the position of the
Company's CEO. Since becoming a shareholder of the Company,
corporate governance has been a priority to Ascendent, and it has
advocated for the introduction of additional independent directors
to the board of the company. Under the merger agreement, Ascendent
explicitly required the Company to nominate three directors who
meet the "independent" requirement for directors under the
applicable Nasdaq rules to enhance the governance of the Board.
Summary: Vote now for a compelling deal
The Board believes that shareholders' interests are best served
by the Ascendent transaction and recommends that shareholders vote
FOR the Ascendent transaction at the upcoming extraordinary general
meeting on February 8, 2024.
We and our advisors stand ready to engage with any shareholders
that wish to discuss this matter in more detail. If you have any
questions, or need assistance in voting, please contact Morrow
Sodali LLC, Hollysys' proxy solicitor, at (800) 662-5200 (toll-free
in US) or +1 (203) 658-9400 or email at
HOLI@info.morrowsodali.com.
Thank you for your continued support,
Hollysys Board of Directors
About Hollysys Automation Technologies Ltd.
Hollysys is a leading automation control system solutions
provider in China, with overseas operations in eight other
countries and regions throughout Asia. Leveraging its
proprietary technology and deep industry know-how, Hollysys
empowers its customers with enhanced operational safety,
reliability, efficiency, and intelligence which are critical to
their businesses. Hollysys derives its revenues mainly from
providing integrated solutions for industrial automation and rail
transportation. In industrial automation, Hollysys delivers the
full spectrum of automation hardware, software, and services
spanning field devices, control systems, enterprise manufacturing
management and cloud-based applications. In rail transportation,
Hollysys provides advanced signaling control and SCADA (Supervisory
Control and Data Acquisition) systems for high-speed rail and urban
rail (including subways). Founded in 1993, with technical expertise
and innovation, Hollysys has grown from a research team
specializing in automation control in the power industry into a
group providing integrated automation control system solutions for
customers in diverse industry verticals. As of June 30, 2023,
Hollysys had cumulatively carried out more than 45,000 projects for
approximately 23,000 customers in various sectors including power,
petrochemical, high-speed rail, and urban rail, in which Hollysys
has established leading market positions.
Safe Harbor Statements
This release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
All statements, other than statements of historical fact included
herein are "forward-looking statements," including statements
regarding the ability of the Company to achieve its commercial
objectives; the business strategy, plans and objectives of the
Company; growth in financial and operational performance of the
Company; and any other statements of non-historical information.
These forward-looking statements are often identified by the use of
forward-looking terminology such as "will," "expects,"
"anticipates," "future," "intends," "plans," "believes,"
"estimates," "target," "confident," or similar expressions involve
known and unknown risks and uncertainties. Such forward-looking
statements, based upon the current beliefs and expectations of
Hollysys' management, are subject to risks and uncertainties, which
could cause actual results to differ from the forward-looking
statements. Although the Company believes that the expectations
reflected in these forward-looking statements are reasonable, they
do involve assumptions, risks and uncertainties, and these
expectations may prove to be incorrect. Investors should not place
undue reliance on these forward-looking statements, which speak
only as of the date of this press release. The Company's actual
results could differ materially from those anticipated in these
forward-looking statements as a result of a variety of factors,
including those discussed in the Company's reports that are filed
with the Securities and Exchange Commission and available on its
website (http://www.sec.gov). All forward-looking statements
attributable to the Company or persons acting on its behalf are
expressly qualified in their entirety by these factors. Other than
as required under the securities laws, the Company does not assume
a duty to update these forward-looking statements.
Contact Information
Company Contact:
Hollysys Automation Technologies Ltd.
www.hollysys.com
+8610-5898-1386
investors@hollysys.com
Media Contacts (Hong Kong and New York):
Brunswick Group
hollysys@brunswickgroup.com
Daniel Del Re (Hong
Kong)
ddelre@brunswickgroup.com
+852 9255 5136
Libby Lloyd (New York)
llloyd@brunswickgroup.com
+1 347 283 3871
View original content to download
multimedia:https://www.prnewswire.com/news-releases/hollysys-recommends-shareholders-vote-for-ascendent-transaction-to-secure-compelling-value-302049401.html
SOURCE Hollysys Automation Technologies Ltd